| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
| Sales | 3,153,960 | 2,928,740 | 2,610,400 | 2,314,390 | 2,089,930 |
| Sales Growth | +7.69% | +12.20% | +12.79% | +10.74% | -32.74% |
| Net Income | 255,610 | -21,670 | 273,140 | 190,640 | -672,130 |
| Net Income Growth | +1,279.56% | -107.93% | +43.28% | +128.36% | -717.09% |
Acadia Healthcr Company (ACHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Acadia Healthcare Company, Inc. provides behavioral health care services in the United States. The U.S. segment comprises acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers, outpatient community-based services, wholly-owned facility, and also comprehensive treatment centers (CTCs). For the services rendered in its facilities, the company receives payments from (i) state governments under their respective Medicaid and other programs; (ii) commercial insurers; (iii) the federal government under the Medicare program administered by CMS; (iv) public funded sources in the U.K.; and (v) individual patients and clients.
Fiscal Year End Date: 12/31